ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)

TuHURA Biosciences, Inc.
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
advanced or metastatic merkel cell carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 405157
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.